BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2438664)

  • 1. Radiation doses from 51Cr-bleomycin.
    Bialobrzeski J; Liniecki J; Greger J; Brykalski D; Zadrozna A
    Nuklearmedizin; 1987 Apr; 26(2):97-104. PubMed ID: 2438664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiation absorbed doses from Co-57- and Co-55 bleomycin.
    Beekhuis H; Nieweg OE
    J Nucl Med; 1984 Apr; 25(4):478-85. PubMed ID: 6085803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 51Cr-bleomycin, a new oncophilic radiopharmaceutical. I. Activity concentrations in transplantable tumours and organs-tissues of mice.
    Rembelska MJ; Liniecki J
    Nuklearmedizin; 1982 Apr; 21(2):62-7. PubMed ID: 6179045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The distribution and dosimetry of 111-IN-bleomycin in man.
    Williams ED; Merrick MV; Lavender JP
    Br J Radiol; 1975 Apr; 48(568):275-8. PubMed ID: 48395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Accumulation mechanism of radioisotopes for diagnosis of tumors (67ga-citrate, 169yb-citrate and 51cr-bleomycin)].
    Orii H
    Rinsho Hoshasen; 1973 Mar; 18(3):211-2. PubMed ID: 4122817
    [No Abstract]   [Full Text] [Related]  

  • 6. Radiochromium distribution in aged rats.
    Wallach S; Verch RL
    J Am Coll Nutr; 1986; 5(3):291-8. PubMed ID: 3734274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Placental transport of chromium.
    Wallach S; Verch RL
    J Am Coll Nutr; 1984; 3(1):69-74. PubMed ID: 6715720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biliary excretion and distribution of 51Cr(III) and 51Cr(VI) in rats.
    Cikrt M; Bencko V
    J Hyg Epidemiol Microbiol Immunol; 1979; 23(3):241-6. PubMed ID: 575148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Distribution study using 57Co-, 51Cr-, 111In- and 99mTc-bleomycin in mice with a solid Ehrlich carcinoma].
    Zimmermann M; Hale T
    Nuklearmedizin; 1976 Aug; 15(4):176-82. PubMed ID: 62345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 51Cr-bleomycin, a new oncophilic radiopharmaceutical. II. Scintigraphic diagnosis of malignant neoplasms.
    Liniecki J; Brykalski D; Pertyński T; Rembelska M; Durski K; Fajndt S
    Nuklearmedizin; 1982 Apr; 21(2):68-71. PubMed ID: 6179046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1-11C-methyl-4-piperidinyl-N-butyrate radiation dosimetry in humans by dynamic organ-specific evaluation.
    Virta JR; Tolvanen T; Någren K; Brück A; Roivainen A; Rinne JO
    J Nucl Med; 2008 Mar; 49(3):347-53. PubMed ID: 18287260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 51Cr-bleomycin in the diagnosis of ocular melanoma.
    Liniecki J; Pertyński T; Krawczykowa Z; Stepień J; Durski K
    Nuklearmedizin; 1983 Dec; 22(6):306-8. PubMed ID: 6199747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organ distribution of 99mTc- and 51Cr-labeled autologous peripheral blood lymphocytes in rabbits.
    Gobuty AH; Robinson RG; Barth RF
    J Nucl Med; 1977 Feb; 18(2):141-6. PubMed ID: 833659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive dose reconstruction methodology for former rocketdyne/atomics international radiation workers.
    Boice JD; Leggett RW; Ellis ED; Wallace PW; Mumma M; Cohen SS; Brill AB; Chadda B; Boecker BB; Yoder RC; Eckerman KF
    Health Phys; 2006 May; 90(5):409-30. PubMed ID: 16607174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PET/CT-derived whole-body and bone marrow dosimetry of 89Zr-cetuximab.
    Makris NE; Boellaard R; van Lingen A; Lammertsma AA; van Dongen GA; Verheul HM; Menke CW; Huisman MC
    J Nucl Med; 2015 Feb; 56(2):249-54. PubMed ID: 25613538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodistribution and dosimetry study of 123I-rh-annexin V in mice and humans.
    Lahorte CM; van de Wiele C; Bacher K; van den Bossche B; Thierens H; van Belle S; Slegers G; Dierckx RA
    Nucl Med Commun; 2003 Aug; 24(8):871-80. PubMed ID: 12869819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biodistribution and dosimetry of 195mPt-cisplatin in normal volunteers. Imaging agent for single photon emission computed tomography.
    Sathekge M; Wagener J; Smith SV; Soni N; Marjanovic-Painter B; Zinn C; Van de Wiele C; D'Asseler Y; Perkins G; Zeevaart JR
    Nuklearmedizin; 2013 Dec; 52(6):222-7. PubMed ID: 24108524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact on 141Ce, 144Ce, 95Zr, and 90Sr beta emitter dose coefficients of photon and electron SAFs calculated with ICRP/ICRU reference adult voxel computational phantoms.
    Li WB; Zankl M; Schlattl H; Petoussi-Henss N; Eckerman KF; Bolch WE; Oeh U; Hoeschen C
    Health Phys; 2010 Oct; 99(4):503-10. PubMed ID: 20838091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Internal dose assessment of 210Po using biokinetic modeling and urinary excretion measurement.
    Li WB; Gerstmann U; Giussani A; Oeh U; Paretzke HG
    Radiat Environ Biophys; 2008 Feb; 47(1):101-10. PubMed ID: 17899149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.